Janus Henderson Group PLC Ascendis Pharma A/S Transaction History
Janus Henderson Group PLC
- $174 Billion
- Q1 2025
A detailed history of Janus Henderson Group PLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Janus Henderson Group PLC holds 4,486,949 shares of ASND stock, worth $706 Million. This represents 0.4% of its overall portfolio holdings.
Number of Shares
4,486,949
Previous 4,380,382
2.43%
Holding current value
$706 Million
Previous $603 Million
15.97%
% of portfolio
0.4%
Previous 0.32%
Shares
24 transactions
Others Institutions Holding ASND
# of Institutions
270Shares Held
61.9MCall Options Held
151KPut Options Held
226K-
Ra Capital Management, L.P. Boston, MA10.3MShares$1.62 Billion33.28% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.48MShares$862 Million4.42% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.22MShares$821 Million13.16% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.26MShares$669 Million1.14% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.05MShares$480 Million0.31% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $8.78B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...